Background Although the three vaccines against coronavirus disease 2019 (Covid-19) that
have received emergency use authorization in the United States are highly effective, …

Background At interim analysis in a phase 3, observer-blinded, placebo-controlled clinical
trial, the mRNA-1273 vaccine showed 94.1% efficacy in preventing coronavirus disease 2019 …

The guideline is intended for use by healthcare providers who care for adult and pediatric
patients with group A streptococcal pharyngitis. The guideline updates the 2002 Infectious …

OBJECTIVES: Prevalence estimates can help clinicians make informed decisions regarding
diagnostic testing of children who present with symptoms of pharyngitis. We conducted a …

The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
exhibits reduced susceptibility to vaccine-induced neutralizing antibodies, requiring a boost to …

Importance Childhood community-acquired pneumonia (CAP) is usually treated with 10 days
of antibiotics. Shorter courses may be effective with fewer adverse effects and decreased …

Background Resistance to erythromycin has been very uncommon among group A streptococci
in the United States. Methods As part of a longitudinal study, we obtained surveillance …

Objective. A 4-year longitudinal study of school-aged children was conducted to describe the
clinical characteristics and epidemiologic features of infections with group A streptococci (…

Background Limiting the duration of antimicrobial treatment constitutes a potential strategy to
reduce the risk of antimicrobial resistance among children with acute otitis media. Methods …

We describe the genome sequence of a macrolide-resistant strain (MGAS10394) of serotype
M6 group A Streptococcus (GAS). The genome is 1,900,156 bp in length, and 8 prophage-…